A Phase 3, Single Arm, Clinical Trial to Study the Contraceptive Efficacy and Safety of the MK- 8342B (Etonogestrel + 17β-Estradiol) Vaginal Ring in Healthy Women 18 Years of Age and Older, At Risk for Pregnancy

Trial Profile

A Phase 3, Single Arm, Clinical Trial to Study the Contraceptive Efficacy and Safety of the MK- 8342B (Etonogestrel + 17β-Estradiol) Vaginal Ring in Healthy Women 18 Years of Age and Older, At Risk for Pregnancy

Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 Oct 2016

At a glance

  • Drugs Estradiol/etonogestrel (Primary)
  • Indications Pregnancy
  • Focus Registrational; Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 28 Sep 2016 Status changed from active, no longer recruiting to discontinued.
    • 10 Aug 2016 Planned End Date changed from 1 Apr 2017 to 1 Sep 2016.
    • 10 Aug 2016 Planned primary completion date changed from 1 Apr 2017 to 1 Sep 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top